Prevention of Bacterial Endocarditis
Adnan S. Dajani(University of Minnesota Medical Center), Richard A. Wiklund(American Heart Association), Arnold S. Bayer(University of California, Los Angeles), Matthew E. Levison, Gregory Zuccaro(Cleveland Clinic), JANE W. NEWBUGER(American Heart Association), Patricia Ferrieri, CECILIA HUTTO(American Heart Association), Ann F. Bolger, Michael H. Gewitz(American Heart Association), Walter R. Wilson(WinnMed), Soraya Nouri, Stanford T. Shulman, Tommy W. Gage, THOMASJ PALIASCH(American Heart Association), Georges Peter(American Heart Association), Kathryn A. Taubert(Brigham and Women's Hospital)
Cited by 571
Related Papers
Markers of Inflammation and Cardiovascular Disease
|Circulation|2003|6.3k
Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children
|Clinical Infectious Diseases|2011|4.2k
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association
|Circulation|2017|3.7k
Prevention of Infective Endocarditis
|Circulation|2007|2.8k